Pulocimab
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb) . Pulocimab can be used for the research of cancers[1].
Product Specifications
CAS Number
2428381-49-9
Product Name Alternative
AK-109
UNSPSC
12352203
Target
VEGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pulocimab.html
Purity
98.42
Solubility
10 mM in DMSO
Smiles
[Pulocimab]
Molecular Weight
(143.721 kDa)
References & Citations
[1]Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82 (12) :1333-1339.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
VEGFR2/KDR/Flk-1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2064606 1.0 µg DNA
RPSAP17 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
sc-476242A 2.5 g
Fmoc-D-aspartic acid b-tert-butyl ester 4-alkoxybenzyl alcohol resin
Sign In for Pricing
View Details DZ41837-Fluoro488 200 µL/Vial
Anti-Anopheles gambiae (African malaria mosquito) AgPPO6 Antibody Fluoro488 Conjugated
Sign In for Pricing
View Details